<DOC>
	<DOCNO>NCT00008294</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Cryosurgery kill cancer cell freeze . Combining one chemotherapy drug cryosurgery give drug different way may kill tumor cell . PURPOSE : Phase I trial study effectiveness intrahepatic intravenous combination chemotherapy without cryosurgery treat unresectable liver metastasis colorectal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Unresectable Liver Metastases From Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerate dose oxaliplatin fluorouracil give leucovorin calcium hepatic intra-arterial floxuridine dexamethasone without cryosurgery ( group I cryosurgery close accrual 10/13/03 ) patient unresectable liver metastasis colorectal cancer . - Determine , preliminarily , anti-tumor activity regimen patient . OUTLINE : This dose-escalation study oxaliplatin fluorouracil . Patients assign one two treatment group . ( Group I close accrual 10/13/03 . ) - Group I ( close accrual 10/13/03 ) : Patients 8 hepatic metastasis metastasis great 5 cm diameter undergo cryosurgery prior chemotherapy . Chemotherapy delay least 4 week cryosurgery . - Group II : Patients 8 hepatic metastasis least one metastases great 5 cm diameter undergo cryosurgery prior chemotherapy . Beginning 2 week pump placement surgery , patient receive floxuridine dexamethasone hepatic intra-arterial infusion continuously day 1-14 ; oxaliplatin IV 2 hour leucovorin calcium IV 2 hour day 15 29 ; fluorouracil IV continuously 48 hour day 15-16 29-30 . Courses repeat every 36 day absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos oxaliplatin fluorouracil maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 3 2 6 patient experience dose-limiting toxicity . PROJECTED ACCRUAL : Approximately 4-72 patient accrue study within 18 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma colon rectum unresectable liver metastasis comprise less 70 % liver parenchyma No extrahepatic disease No ascites PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 2.0 mg/dL No hepatic encephalopathy Renal : Creatinine great 1.5 mg/dL Other : Not pregnant nursing Negative pregnancy test No obstruction gastrointestinal tract genitourinary tract No symptomatic peripheral sensory neuropathy No active infection No malignancy except resectable primary colorectal carcinoma PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior floxuridine If undergoing cryosurgery ( group I cryosurgery close accrual 10/13/03 ) , must receive one follow : Systemic chemotherapy metastatic disease Adjuvant therapy within past 6 month comprise fluorouracil without levamisole resect primary colorectal carcinoma Adjuvant therapy within past 12 month comprise fluorouracil leucovorin calcium without levamisole resect primary colorectal carcinoma Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy liver Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>